Please login to the form below

Not currently logged in


This page shows the latest Hydroxychloroquine news and features for those working in and with pharma, biotech and healthcare.

Facts are stubborn things

Facts are stubborn things

Or that taking ivermectin, a parasitic agent used in veterinary medicine, or hydroxychloroquine may help reduce being hospitalised for COVID-19.

Latest news

  • WHO to test three more potential COVID-19 treatments WHO to test three more potential COVID-19 treatments

    Last year, WHO announced that four drugs tested in its Solidarity trial, touted as effective treatments for severe COVID-19 infection – remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon – had little or no ... Hydroxychloroquine and

  • WHO trial casts doubt on remdesivir's efficacy WHO trial casts doubt on remdesivir's efficacy

    The interim results, published on the pre-print server medRxiv, showed that remdesivir, along with hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have ‘little or no effect’ on 28-day

  • Pearls of wisdom Pearls of wisdom

    Hydroxychloroquine does not work. Ingestion of disinfectants, hand sanitiser and light into the body do not work either.

  • Speed kills Speed kills

    On 22 May, The Lancet published a research paper about hydroxychloroquine, the antimalarial drug, as a potential treatment for COVID-19. ... claimed that the use of hydroxychloroquine carried a greater risk of heart arrhythmia and death.

  • WHO takes stock of global COVID-19 R&D progress WHO takes stock of global COVID-19 R&D progress

    The WHO also took the decision to discontinue the Solidarity Trial’s hydroxychloroquine and lopinavir/ritonavir arms following a review of evidence obtained at the interim analysis. ... These results showed that neither hydroxychloroquine nor 

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts


Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...